AdobeStock_304392003

Consulting

Scientific expertise for regulatory engagements, study design, and more.

 

Expert guidance, every step of the way

When your evidence needs to be rigorous, defensible, and ready for regulatory review, our consulting team is here to support you.

Led by internationally recognized experts — including leaders ranked in the world’s top 2% of most-cited scientists — we provide practical guidance across study design, strategy, and regulatory engagements to ensure your evidence generation is robust, valid, and actionable.

Two men in the office talking with each sat at a desk

How can we support your research today?

Explore our expert consulting services

RWE consulting

Expert guidance for regulatory engagements and RWD study design, led by recognized industry leaders.

Learn more

RWE research

Expert support from study design to dissemination to generate trusted evidence. Consultation to strengthen your evidence strategies and improve research outcomes from leaders in the field.

Learn more

External control arms

Generate representative, fit-for-purpose control data with TriNetX external control arms.

Learn more

Epidemiological services

two people, a man and a woman looking at a transparent wall and the man writing on the wall

Our epidemiological consulting team brings decades of experience to advance your goals through every stage of the evidence generation journey.

Learn more

Speak to one of our experts

Got a question, query, or just want to learn more? Our RWD experts are a click away

Want to learn more?

Explore our latest articles, news, and whitepapers

Terminal Ileum Resection and Colorectal Cancer Risk in Crohn’s Disease: What 19 Years of Real-World Data Show
Blogs

This independently conducted Brief Report, conducted utilizing the TriNetX LIVE™ platform, makes that case in terms that Health Economics and Outcomes Research teams need to confront directly with additional research and contextualization.

Deriving Breast Cancer Stage from Electronic Health Records: A Comparison of Gradient Boosting and Large Language Models Without Task-Specific Training
Poster Presentations

This study compares the performance of a classic ML model and a LLM in deriving breast cancer stage from structured EHR data.

Real-time estimation of the prevalence of exposures during pregnancy to novel therapeutics approved from 2021 to 2024
Poster Presentations

Electronic health record RWD sources may be a more viable approach to monitoring
medication use during pregnancy. We estimate exposure to novel therapeutics during pregnancy in a large EHR research network.

Conception of a framework to assess the capability of real-world data to respond to infectious disease research objectives
Poster Presentations

Infectious disease research spanning stakeholders and purposes can benefit from the inclusion of real-world data (RWD). The fit for RWD in
studying specific ID research components is not well-established beyond study-specific assessment.

AdobeStock_231552647

Contact TriNetX

Need to reach out? We’re here to help

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
TriNetX Marketing Opt In
By subscribing to promotional updates, you agree to the TriNetX Privacy Policy and receiving relevant TriNetX marketing and other promotional emails, from which you can opt out at any time.
TriNetX Privacy Policy*
By submitting this form, you agree to receiving marketing and other promotional emails from us. For opt-out information, as well as TriNetX privacy practices and commitment to protecting your privacy, please review the TriNetX Privacy Policy.
This field is hidden when viewing the form
From Gravity Form

Meet